Learn More
Medchemexpress LLC Terazosin hydrochloride dihydrate | 70024-40-7 | 99.9% | 50 MG

Supplier: Medchemexpress LLC HYB0371A50MG
Terazosin hydrochloride dihydrate is a quinazoline derivative, and it acts as a competitive and orally active α1-adrenoceptor antagonist. It functions by relaxing blood vessels and facilitating the opening of the bladder. This compound shows potential for treating benign prostatic hyperplasia (BPH) and high blood pressure. It is intended for research use only and is not sold to patients.
- Competitively blocks α1-adrenoceptors.
- Can be administered orally.
- Helps in relaxing blood vessels.
- Aids in the opening of the bladder.
- Has potential for the treatment of benign prostatic hyperplasia (BPH) and high blood pressure.
- Suitable for research applications.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.